Theralase Technologies Inc. (TSXV:TLT)
Canada flag Canada · Delayed Price · Currency is CAD
0.2300
0.00 (0.00%)
May 22, 2026, 3:33 PM EST

Theralase Technologies Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.180.270.041.513.69
Cash & Short-Term Investments
0.180.270.041.513.69
Cash Growth
-31.94%512.05%-97.09%-59.13%-53.15%
Accounts Receivable
1.20.550.390.20.09
Other Receivables
-0.160.210.240.21
Receivables
1.20.710.60.440.3
Inventory
0.510.550.660.490.57
Prepaid Expenses
0.140.060.20.070.44
Other Current Assets
-0---
Total Current Assets
2.031.581.52.55
Property, Plant & Equipment
0.450.610.861.110.87
Long-Term Accounts Receivable
1.021.060.920.550.08
Other Long-Term Assets
--0---
Total Assets
3.493.253.284.165.94
Accounts Payable
-0.360.680.330.5
Accrued Expenses
-0.520.30.270.34
Short-Term Debt
0.26----
Current Portion of Leases
0.110.10.090.090.04
Other Current Liabilities
1.26----
Total Current Liabilities
1.620.991.080.680.87
Long-Term Leases
0.090.190.290.39-
Total Liabilities
1.721.181.371.070.87
Common Stock
50.8948.9246.4444.5342.12
Additional Paid-In Capital
18.1617.5812.4911.3710.94
Retained Earnings
-71.62-67.5-63.24-58.45-53.09
Comprehensive Income & Other
4.353.066.225.645.1
Shareholders' Equity
1.782.071.913.095.07
Total Liabilities & Equity
3.493.253.284.165.94
Total Debt
0.460.290.390.470.04
Net Cash (Debt)
-0.28-0.03-0.341.033.66
Net Cash Growth
----71.69%-53.06%
Net Cash Per Share
-0.00-0.00-0.000.000.02
Filing Date Shares Outstanding
260.67248.81235.13216.5204.43
Total Common Shares Outstanding
260.67247.78228.46216.5204.28
Working Capital
0.40.60.421.824.12
Book Value Per Share
0.010.010.010.010.02
Tangible Book Value
1.782.071.913.095.07
Tangible Book Value Per Share
0.010.010.010.010.02
Machinery
-1.681.661.761.69
Leasehold Improvements
-0.030.030.260.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.